Send to:

Choose Destination
See comment in PubMed Commons below
Duodecim. 2012;128(18):1851-8.

[Pancreatic adenocarcinoma--a therapeutic challenge].

[Article in Finnish]

Author information

  • 1TYKS, syöpätautien klinikka ja Turun yliopisto.


In Finland, the 5-year survival rate of pancreatic adenocarcinoma is 3%. Surgery is the only treatment that may be curative. Adjuvant chemotherapy after radical surgery is beneficial and patients with locally advanced disease may also benefit from chemoradiotherapy. The treatment of metastatic pancreatic cancer, expert symptomatic and palliative care is essential. New therapeutic approaches, e.g. combined cytostatics and/or targeted biologic drugs are being investigated to improve patient outcome.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk